Adegoke O. Adeniji

Development of Potent and Selective Inhibitors of Aldo–Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) Based on<i>N</i>-Phenyl-Aminobenzoates and Their Structure–Activity Relationships

Adegoke O. Adeniji, Barry M. Twenter, Michael C. Byrns et al. · Journal of Medicinal Chemistry · 2012 · 104 citations · Full text

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer

Andy J. Liedtke, Adegoke O. Adeniji, Mo Chen et al. · Journal of Medicinal Chemistry · 2013 · 94 citations · Full text

Indomethacin Analogues, Castrate-resistant Prostate Cancer, Pharmacotherapy +17

Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer

Mo Chen, Adegoke O. Adeniji, Barry M. Twenter et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 65 citations · Full text

Urology, Medicine, Crystal Structures +7

Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)

Adegoke O. Adeniji, Barry M. Twenter, Michael C. Byrns et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 47 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Benzoic Acids +10

Discovery of (<i>R</i>)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor

Adegoke O. Adeniji, Md. Jashim Uddin, Tianzhu Zang et al. · Journal of Medicinal Chemistry · 2016 · 40 citations · Full text